Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Buy
2,770
+156
+6% +$15.9K ﹤0.01% 1825
2025
Q4
$263K Buy
2,614
+544
+26% +$53.6K ﹤0.01% 1886
2025
Q3
$179K Buy
2,070
+188
+10% +$14.9K ﹤0.01% 2064
2025
Q2
$144K Buy
1,882
+46
+3% +$3.37K ﹤0.01% 2231
2025
Q1
$130K Buy
1,836
+680
+59% +$53.2K ﹤0.01% 2255
2024
Q4
$90.5K Buy
+1,156
New +$108K ﹤0.01% 2445

Other funds holding NUVL

US Bancorp's NUVL Position: Q1 2026 in Review

US Bancorp increased its Nuvalent (NUVL) stake by 6% in Q1 2026, buying an estimated $15.9K and bringing the position to 2,770 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

US Bancorp first reported a position in NUVL in Q4 2024 and has held it in 6 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • US Bancorp held 2,770 shares of Nuvalent worth $284K as of Q1 2026.
  • US Bancorp bought 156 Nuvalent shares in Q1 2026, an estimated $15.9K.
  • Nuvalent made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #1825 holding.
  • US Bancorp first reported a position in Nuvalent in Q4 2024 and has held it in 6 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.